These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 1977438

  • 1. Pharmacodynamic without pharmacokinetic interaction between cicloprolol, a partial beta 1-adrenoceptor agonist, and digoxin in healthy subjects.
    Weber S, Kahan A, Pinquier JL, Julien J, Rosenzweig P, Bianchetti G, Morselli PL, Dessault O, De Lauture D, Strauch G.
    Br J Clin Pharmacol; 1990 Sep; 30(3):411-6. PubMed ID: 1977438
    [Abstract] [Full Text] [Related]

  • 2. [Hemodynamic effects at rest and exertion of a new partial beta-agonist (cicloprolol) in moderated cardiac failure].
    Rigaud M, Hamoir V, Chabanier A, Neveux E, Cazor JL, Bardet J, Bourdarias JP.
    Arch Mal Coeur Vaiss; 1988 Oct; 81(10):1251-8. PubMed ID: 2906233
    [Abstract] [Full Text] [Related]

  • 3. Combined invasive and noninvasive study of left ventricular systolic and diastolic function following acute administration of cicloprolol to subjects with normal cardiac function.
    Bonandi L, Metra M, Niccoli L, Ettori F, Nodari S, Dei Cas L, Visioli O.
    Cardiovasc Drugs Ther; 1992 Oct; 6(5):513-7. PubMed ID: 1360256
    [Abstract] [Full Text] [Related]

  • 4. Investigation of possible pharmacokinetic and pharmacodynamic interactions between epanolol and digoxin.
    Lefebvre RA, Bogaert MG, Duprez D.
    Eur J Clin Pharmacol; 1990 Oct; 38(5):505-7. PubMed ID: 1974206
    [Abstract] [Full Text] [Related]

  • 5. An evaluation of the safety of the beta-modulator cicloprolol in chronic heart failure.
    Cocco G, Alfiero R, Pouleur H.
    Clin Cardiol; 1992 Jan; 15(1):38-42. PubMed ID: 1347258
    [Abstract] [Full Text] [Related]

  • 6. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE, Cavero I, Manoury P, Lefevre-Borg F, Langer SZ.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [Abstract] [Full Text] [Related]

  • 7. Studies of the agonist and antagonist activity of cicloprolol in man.
    McCaffrey PM, Burke M, Riddell JG, Shanks RG.
    Eur J Clin Pharmacol; 1988 Sep; 34(6):569-75. PubMed ID: 3169110
    [Abstract] [Full Text] [Related]

  • 8. Comparisons of the inotropic effects of the beta 1-adrenoceptor partial agonists SL 75.177.10 and ICI 118,587 with digoxin on the intact canine heart.
    Pouleur H, Van Mechelen H, Balasim H, Rousseau MF, Charlier AA.
    J Cardiovasc Pharmacol; 1984 Sep; 6(4):720-6. PubMed ID: 6206332
    [Abstract] [Full Text] [Related]

  • 9. Effect of cicloprolol in intraocular pressure in healthy volunteers.
    Mekki QA, Turner P.
    Br J Clin Pharmacol; 1988 Jul; 26(1):89-91. PubMed ID: 2904826
    [Abstract] [Full Text] [Related]

  • 10. Comparative effects of atenolol and cicloprolol on cardiac performance in coronary heart disease.
    Silke B, Verma SP, Sharma SK, Frais MA, Reynolds G, Taylor SH.
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):155-61. PubMed ID: 2468927
    [Abstract] [Full Text] [Related]

  • 11. Teriparatide has no effect on the calcium-mediated pharmacodynamics of digoxin.
    Benson CT, Voelker JR.
    Clin Pharmacol Ther; 2003 Jan; 73(1):87-94. PubMed ID: 12545147
    [Abstract] [Full Text] [Related]

  • 12. The effects of the partial beta 1-agonist xamoterol on heart rate and ventricular arrhythmias in patients with mild to moderate heart failure.
    Virk SJ, Anfilogoff NH, Lawson N, Qiang F, Murray RG, Littler WA, Davies MK.
    Eur Heart J; 1990 Oct; 11(10):876-84. PubMed ID: 1979946
    [Abstract] [Full Text] [Related]

  • 13. The cardiovascular effects of xamoterol, a beta 1-adrenoceptor partial agonist, in healthy volunteers at rest.
    Hashimoto T, Shiina A, Toyo-Oka T, Hosoda S, Kondo K.
    Br J Clin Pharmacol; 1986 Mar; 21(3):259-65. PubMed ID: 2421751
    [Abstract] [Full Text] [Related]

  • 14. Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation.
    Ang EL, Chan WL, Cleland JG, Moore D, Krikler SJ, Alexander ND, Oakley CM.
    Br Heart J; 1990 Oct; 64(4):256-60. PubMed ID: 1977430
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. No pharmacokinetic or pharmacodynamic interaction between digoxin and the oral direct thrombin inhibitor ximelagatran in healthy volunteers.
    Sarich TC, Schützer KM, Wollbratt M, Wall U, Kessler E, Eriksson UG.
    J Clin Pharmacol; 2004 Aug; 44(8):935-41. PubMed ID: 15286098
    [Abstract] [Full Text] [Related]

  • 19. Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
    Fitzgerald DE, Harry JD.
    Br J Clin Pharmacol; 1989 Aug; 28 Suppl 1(Suppl 1):73S-74S. PubMed ID: 2572260
    [Abstract] [Full Text] [Related]

  • 20. Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial.
    Hornestam B, Jerling M, Karlsson MO, Held P, DAAf Trial Group.
    Eur J Clin Pharmacol; 2003 Mar; 58(11):747-55. PubMed ID: 12634981
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.